DK172711B1 - Fremgangsmåde, kloningsvektor og grampositiv bakteriecelle til fremstilling af et forud bestemt protein, fremgangsmåde til - Google Patents

Fremgangsmåde, kloningsvektor og grampositiv bakteriecelle til fremstilling af et forud bestemt protein, fremgangsmåde til Download PDF

Info

Publication number
DK172711B1
DK172711B1 DK198101095A DK109581A DK172711B1 DK 172711 B1 DK172711 B1 DK 172711B1 DK 198101095 A DK198101095 A DK 198101095A DK 109581 A DK109581 A DK 109581A DK 172711 B1 DK172711 B1 DK 172711B1
Authority
DK
Denmark
Prior art keywords
predetermined protein
protein
gene
subtilis
predetermined
Prior art date
Application number
DK198101095A
Other languages
Danish (da)
English (en)
Other versions
DK109581A (da
Inventor
Shing Chang
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of DK109581A publication Critical patent/DK109581A/da
Application granted granted Critical
Publication of DK172711B1 publication Critical patent/DK172711B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
DK198101095A 1980-03-10 1981-03-10 Fremgangsmåde, kloningsvektor og grampositiv bakteriecelle til fremstilling af et forud bestemt protein, fremgangsmåde til DK172711B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12853780A 1980-03-10 1980-03-10
US12853780 1980-03-10
US22180080A 1980-12-31 1980-12-31
US22180080 1980-12-31

Publications (2)

Publication Number Publication Date
DK109581A DK109581A (da) 1981-09-11
DK172711B1 true DK172711B1 (da) 1999-06-07

Family

ID=26826682

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198101095A DK172711B1 (da) 1980-03-10 1981-03-10 Fremgangsmåde, kloningsvektor og grampositiv bakteriecelle til fremstilling af et forud bestemt protein, fremgangsmåde til

Country Status (9)

Country Link
EP (1) EP0036259B1 (de)
AU (1) AU545912B2 (de)
CA (1) CA1182408A (de)
DE (1) DE3177067D1 (de)
DK (1) DK172711B1 (de)
ES (2) ES8307895A1 (de)
FI (1) FI810722L (de)
IL (1) IL62327A0 (de)
NO (1) NO810803L (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
AU8300282A (en) * 1981-04-29 1982-11-04 Biogen N.V. Bacillus cloning vectors and method of expressing foreign dna
US4508826A (en) * 1982-04-15 1985-04-02 Merck & Co., Inc. Bacteriophage DNA cloning vector TG1 and microorganisms containing TG1
US4460689A (en) * 1982-04-15 1984-07-17 Merck & Co., Inc. DNA Cloning vector TG1, derivatives, and processes of making
FR2537602B2 (fr) * 1982-09-24 1986-10-24 Centre Nat Rech Scient Nouvel adn recombinant perfectionne utile dans la preparation d'a-amylase par bacillus subtilis
FR2533583A1 (fr) * 1982-09-24 1984-03-30 Centre Nat Rech Scient Nouvel adn recombinant utile dans la preparation d'a-amylase
US4559300A (en) * 1983-01-18 1985-12-17 Eli Lilly And Company Method for using an homologous bacillus promoter and associated natural or modified ribosome binding site-containing DNA sequence in streptomyces
US4783405A (en) * 1983-01-18 1988-11-08 Eli Lilly And Company Recombinant DNA expression vectors useful in bacillus and other host cells
US4585739A (en) * 1983-03-07 1986-04-29 E. I. Du Pont De Nemours And Company Plasmid for foreign gene expression in B. subtilis
DK138984A (da) * 1983-03-08 1984-09-09 Rikagaku Kenkyusho Plasmid, fremgangsmaade til fremstilling heraf, mikroorganismer indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
US4912046A (en) * 1983-06-27 1990-03-27 Genentech, Inc. Portable inducible control system
US5624829A (en) * 1984-07-03 1997-04-29 Gist-Brocades, B.V. Transformed industrial bacillus strains and methods for making and using them
JP2669457B2 (ja) * 1983-07-06 1997-10-27 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ 工業微生物種中の分子クローニングおよび発現
JPS60137291A (ja) * 1983-12-26 1985-07-20 Takeda Chem Ind Ltd 発現ベクター
EP0189481B1 (de) * 1984-07-13 1991-01-23 Chiron Corporation Insulinähnlicher Wachstumsfaktor II
JPH062074B2 (ja) * 1984-07-27 1994-01-12 國男 山根 オリゴペプチドの製法
SE8403929L (sv) * 1984-07-31 1986-02-21 Sten Gatenbeck Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
US5032510A (en) * 1984-09-26 1991-07-16 Eli Lilly And Company Method for expression and secretion in bacillus
IT1177378B (it) * 1984-12-11 1987-08-26 Anic Spa Vettore plasmidico psm112 ad espressione in bacillus subtilis
IT1208514B (it) * 1985-03-19 1989-07-10 Eniricerche Spa Vettori plasmidici ad espressione in escherichia coli e/o bacillussubtilis.
US4769327A (en) * 1985-03-29 1988-09-06 Biotechnica International, Inc. Secretion vector
IT1186750B (it) * 1985-07-10 1987-12-16 Eniricerche Spa Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni
US4977089A (en) * 1987-01-30 1990-12-11 Eli Lilly And Company Vector comprising signal peptide-encoding DNA for use in Bacillus and other microorganisms
DK0574402T3 (da) 1990-11-26 1998-05-18 Chiron Corp Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
GB9513371D0 (en) 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
US5629167A (en) 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
BR9813930A (pt) 1997-11-06 2006-12-19 Chiron Spa antìgeno neisserial
WO1999036544A2 (en) 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
WO2001031019A2 (en) 1999-10-29 2001-05-03 Chiron Spa Neisserial antigenic peptides
JP5102414B2 (ja) 1998-05-01 2012-12-19 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 髄膜炎菌抗原および組成物
CN100392082C (zh) 1999-04-30 2008-06-04 启龙股份公司 保守的奈瑟球菌抗原
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
CN1416352B (zh) 2000-01-17 2011-05-25 启龙股份公司 含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗
EP1328543B1 (de) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nukleinsäuren und proteine von gruppen a und b-streptokokken
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
MXPA04000653A (es) 2001-07-27 2004-11-22 Chiron Srl Adhesinas de meningococcus nada, app y orf 40.
ES2386386T3 (es) 2001-12-12 2012-08-20 Novartis Vaccines And Diagnostics S.R.L. Inmunización contra Chlamydia trachomatis
EP1513945A4 (de) 2002-05-24 2008-12-24 Restoragen Inc Verfahren zur universellen enzymatischen herstellung bioaktiver peptide
WO2003099854A2 (en) 2002-05-24 2003-12-04 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
ATE466875T1 (de) 2002-11-15 2010-05-15 Novartis Vaccines & Diagnostic Unerwartete oberflächenproteine in neisseria meningitidis
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
SI1704234T1 (sl) 2003-11-21 2012-08-31 Nps Pharma Inc Proizvodnja glukagonu podobnih peptidov 2 in analogov
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
US20110206692A1 (en) 2006-06-09 2011-08-25 Novartis Ag Conformers of bacterial adhesins
EP2245048B1 (de) 2008-02-21 2014-12-31 Novartis AG Meningokokken-fhbp-polypeptide
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
AU2010288240B2 (en) 2009-08-27 2014-03-27 Novartis Ag Hybrid polypeptides including meningococcal fHBP sequences
AU2010310985B2 (en) 2009-10-27 2014-11-06 Glaxosmithkline Biologicals S.A. Modified meningococcal fHBP polypeptides
FR2954349A1 (fr) 2009-12-22 2011-06-24 Agronomique Inst Nat Rech Sulfatase modifiant selectivement les glycosaminoglycanes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
FI792481A (fi) * 1978-08-11 1980-02-12 Univ California Syntes av enkaroytiskt protein genom anvaendning av mikro-organismer
FR2442271A1 (fr) * 1978-11-27 1980-06-20 Pasteur Institut Vecteur permettant l'insertion d'un gene procaryote ou eucaryote, et l'excretion de la proteine exprimee
GB2048894A (en) * 1979-05-11 1980-12-17 Gist Brocades Nv Plasmid
GR70279B (de) * 1979-09-12 1982-09-03 Univ California
IL61982A (en) * 1980-02-15 1984-01-31 Cpc International Inc Genetically engineered microorganisms for massive production of amyloytic enzymes and process for preparing same using the corresponding recombinant dnas containing amylase coding genes
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis

Also Published As

Publication number Publication date
NO810803L (no) 1981-09-11
DK109581A (da) 1981-09-11
EP0036259A2 (de) 1981-09-23
CA1182408A (en) 1985-02-12
ES510011A0 (es) 1983-06-01
AU6790281A (en) 1981-09-17
AU545912B2 (en) 1985-08-08
FI810722L (fi) 1981-09-11
ES500201A0 (es) 1983-07-01
EP0036259A3 (en) 1982-06-09
IL62327A0 (en) 1981-05-20
EP0036259B1 (de) 1989-06-14
ES8307895A1 (es) 1983-07-01
DE3177067D1 (en) 1989-07-20
ES8306796A1 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
DK172711B1 (da) Fremgangsmåde, kloningsvektor og grampositiv bakteriecelle til fremstilling af et forud bestemt protein, fremgangsmåde til
Smith et al. Construction and use of signal sequence selection vectors in Escherichia coli and Bacillus subtilis
US5037760A (en) Secretory signal selection vectors for extracellular protein synthesis bacilli
US4711843A (en) Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
US4965197A (en) Coryneform expression and secretion system
DK175738B1 (da) Molekylær kloning og ekspression af gener, der koder for proteolytiske enzymer
Heinrich et al. The molecular organization of the lysostaphin gene and its sequences repeated in tandem
Kornacker et al. Molecular characterization of pulA and its product, pullulanase, a secreted enzyme of Klebsielia pneumoniae UNF5023
Anné et al. Streptomyces lividans as host for heterologous protein production
US4801537A (en) Vector for expression of polypeptides in bacilli
WO1993024631A1 (en) PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS)
WO1984000773A1 (en) Recombinant dna molecule, transformed microorganism and process for producing staphylococcal protein a
US5011772A (en) High yield protein production system
US5585253A (en) Extracellular serine protease and a Bacillus subtilis alkaline neutral an serine protease mutant strain
US5429950A (en) Heterologous gene expression in bacillus subtilis: fusion approach
EP0546049B1 (de) Eine methode für die schnelle selektion von effizienten sekretionsvektoren
JP3154720B2 (ja) 誘導性発現ベクター
EP0133756A2 (de) Vektor für die Expression von Polypeptiden
JPH0146111B2 (de)
DK175020B1 (da) Fremgangsåde til udtrykkelse og ekstracellulær udskillelse af proteiner i G(-)bakterie, rekombinant DNA-konstruktion og plasmidvektor kodende herfor, samt G(-)bakterie indeholdende disse
WO1988009821A1 (en) Coryneform expression and secretion system
US4952508A (en) Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
US5858727A (en) Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms
Liebl et al. Molecular cloning and nucleotide sequence of a gene involved in the production of extracellular DNase by Corynebacterium glutamicum
CA1243266A (en) Method and vector organism for controlled accumulation of cloned heterologous gene products in bacillus subtilis

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired